van Eijk, Maarten https://orcid.org/0000-0001-7246-4857
Yu, Huixin
Sawicki, Emilia
de Weger, Vincent A.
Nuijen, Bastiaan
Dorlo, Thomas P. C.
Beijnen, Jos H.
Huitema, Alwin D. R.
Funding for this research was provided by:
ZonMw (40-41200-98-004)
Article History
Received: 16 December 2021
Accepted: 4 June 2022
First Online: 7 July 2022
Declarations
:
: Bastiaan Nuijen and Jos H. Beijnen are inventors and hold a patent on oral ModraPac formulations. Jos H. Beijnen is a (part-time) employee and (indirect) shareholder of Modra Pharmaceuticals Holding B.V., a spin-off company that develops oral taxane formulations. The other authors declare that they have no conflict of interest.